166 related articles for article (PubMed ID: 21468700)
1. Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer.
Schimanski CC; Moehler M; Gockel I; Zimmermann T; Lang H; Galle PR; Berger MR
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1139-45. PubMed ID: 21468700
[TBL] [Abstract][Full Text] [Related]
2. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?
Conzelmann M; Linnemann U; Berger MR
Int J Colorectal Dis; 2005 Mar; 20(2):137-46. PubMed ID: 15459772
[TBL] [Abstract][Full Text] [Related]
4. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
5. Detection of disseminated tumour cells in the liver of colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Eur J Surg Oncol; 2005 Feb; 31(1):38-44. PubMed ID: 15642424
[TBL] [Abstract][Full Text] [Related]
6. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
Mostert B; Jiang Y; Sieuwerts AM; Wang H; Bolt-de Vries J; Biermann K; Kraan J; Lalmahomed Z; van Galen A; de Weerd V; van der Spoel P; Ramírez-Moreno R; Verhoef C; Ijzermans JN; Wang Y; Gratama JW; Foekens JA; Sleijfer S; Martens JW
Int J Cancer; 2013 Jul; 133(1):130-41. PubMed ID: 23233388
[TBL] [Abstract][Full Text] [Related]
7. K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer.
Schimanski CC; Zimmermann T; Schmidtmann I; Gockel I; Lang H; Galle PR; Moehler M; Berger MR
Int J Colorectal Dis; 2010 Feb; 25(2):181-6. PubMed ID: 19936766
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13.
Kawamata H; Yamashita K; Kojo K; Ushiku H; Ooki A; Watanabe M
Genomics; 2015 Aug; 106(2):71-5. PubMed ID: 26026309
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.
Kuramochi H; Nakajima G; Kaneko Y; Nakamura A; Inoue Y; Yamamoto M; Hayashi K
BMC Cancer; 2012 Mar; 12():88. PubMed ID: 22409860
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
11. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration.
Zimmermann T; Moehler M; Gockel I; Sgourakis GG; Biesterfeld S; Müller M; Berger MR; Lang H; Galle PR; Schimanski CC
Int J Colorectal Dis; 2010 Apr; 25(4):417-24. PubMed ID: 20054600
[TBL] [Abstract][Full Text] [Related]
12. Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.
Rao B; Gao Y; Huang J; Gao X; Fu X; Huang M; Yao J; Wang J; Li W; Zhang J; Liu H; Wang L; Wang J
Int J Colorectal Dis; 2011 May; 26(5):593-601. PubMed ID: 21404058
[TBL] [Abstract][Full Text] [Related]
13. Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer.
Kamal MM; Youssef OZ; Lotfy AN; Elsaed ET; Fawzy MM
J Egypt Natl Canc Inst; 2012 Sep; 24(3):115-22. PubMed ID: 22929917
[TBL] [Abstract][Full Text] [Related]
14. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
Bokemeyer C; Bondarenko I; Hartmann JT; de Braud F; Schuch G; Zubel A; Celik I; Schlichting M; Koralewski P
Ann Oncol; 2011 Jul; 22(7):1535-1546. PubMed ID: 21228335
[TBL] [Abstract][Full Text] [Related]
15. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
16. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer.
Su N; Xu XY; Chen H; Gao WC; Ruan CP; Wang Q; Sun YP
Tohoku J Exp Med; 2010 Dec; 222(4):243-50. PubMed ID: 21127395
[TBL] [Abstract][Full Text] [Related]
18. Interlaboratory comparison of K-ras testing by real-time PCR and RFLP in colorectal cancer samples.
Lanthaler AJ; Spizzo G; Mitterer M; Mian C; Mazzoleni G
Diagn Mol Pathol; 2011 Jun; 20(2):90-3. PubMed ID: 21532493
[TBL] [Abstract][Full Text] [Related]
19. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
[TBL] [Abstract][Full Text] [Related]
20. Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients.
Pérez-Ruiz E; Rueda A; Pereda T; Alcaide J; Bautista D; Rivas-Ruiz F; Villatoro R; Pérez D; Redondo M
Tumour Biol; 2012 Dec; 33(6):1829-35. PubMed ID: 22791568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]